As highly-multiplexed tissue imaging continues to demonstrate its potential for drug development, Propath now offers a comprehensive service for ultra-high plex immunofluorescence.


The COMETTM is a high-throughput automated immunofluorescence staining platform, enabling imaging of up to 40 protein targets from a single tissue section.
The platform allows multiplexing with standard antibody libraries, with no conjugated or barcoding needed.
Using a sequential IF (seqIFTM) approach means that highly multiplexed panels can be developed in days – not months – with high tissue preservation and signal stability.

As the only high-throughput solution available currently for hyperplex immunofluorescence staining, the COMETTM offers several advantages:








A significant advantage of the COMET is that the system is open for use with commercially available, non-conjugated, primary antibodies, although Propath can provide a list of suggested markers and clones that have been tested and optimised.
We are also able to use clients’ existing validated library of antibodies to develop hyper-plex assays within days.
Alternatively clients may start with one of Propath’s modular pre-optimised panels, with the option to add additional markers easily.
COMET is designed to deliver maximum throughput for high-plex assays. We are able to process up to 40 slides of 20-plex per week; and 124 slides of 40-plex per week.
12.5 x 12.5 mm.
It is possible to reduce the imaging area if an entire section is not required. Automated tissue-detection also minimises imaging of empty glass and optimises scan time and file size.
The output format is OME-TIFF.